相关实验视频

Updated: Jul 19, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

9.1K

可切除胃癌辅助化疗的益处:一个元分析

, Xavier Paoletti, Koji Oba

    JAMA
    |May 6, 2010
    PubMed
    概括

    辅助化疗显著改善了胃癌患者在手术后的生存率. 这一元分析证实基于甲的疗法可以降低死亡风险,提高整体和无疾病生存率.

    更多相关视频

    Single Incision Plus One Port Laparoscopic Proximal Gastrectomy with Double Channel Anastomosis for Gastric Cancer Treatment03:32

    Single Incision Plus One Port Laparoscopic Proximal Gastrectomy with Double Channel Anastomosis for Gastric Cancer Treatment

    Published on: December 27, 2024

    2.0K
    Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer05:30

    Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer

    Published on: October 31, 2025

    464

    相关概念视频

    Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

    Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

    5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...